[
  {
    "title": "Drug Stocks Are the New Safe Bet in a Shaky Market",
    "published": 1740726000,
    "day_prices": {
      "2025-02-28T14:30:00+00:00": 112.1500015258789,
      "2025-02-28T15:30:00+00:00": 112.05000305175781,
      "2025-02-28T16:30:00+00:00": 112.50499725341797,
      "2025-02-28T17:30:00+00:00": 112.93000030517578,
      "2025-02-28T18:30:00+00:00": 112.73500061035156,
      "2025-02-28T19:30:00+00:00": 113.63999938964844,
      "2025-02-28T20:30:00+00:00": 114.36000061035156
    },
    "sentiment": 0.39812377095222473
  },
  {
    "title": "Healthcare Stocks Should Be Hurting. How the Sector Became This Year\u2019s Top Performer.",
    "published": 1740500160,
    "day_prices": {
      "2025-02-25T14:30:00+00:00": 111.0999984741211,
      "2025-02-25T15:30:00+00:00": 112.05999755859375,
      "2025-02-25T16:30:00+00:00": 111.37000274658203,
      "2025-02-25T17:30:00+00:00": 111.52999877929688,
      "2025-02-25T18:30:00+00:00": 111.45999908447266,
      "2025-02-25T19:30:00+00:00": 111.37000274658203,
      "2025-02-25T20:30:00+00:00": 111.875
    },
    "sentiment": 0.9493907690048218
  },
  {
    "title": "Hartford Dividend And Growth Fund Q4 2024 Commentary",
    "published": 1740405780,
    "day_prices": {
      "2025-02-24T14:30:00+00:00": 109.56999969482422,
      "2025-02-24T15:30:00+00:00": 111.45999908447266,
      "2025-02-24T16:30:00+00:00": 111.48999786376953,
      "2025-02-24T17:30:00+00:00": 111.3550033569336,
      "2025-02-24T18:30:00+00:00": 111.51499938964844,
      "2025-02-24T19:30:00+00:00": 111.16000366210938,
      "2025-02-24T20:30:00+00:00": 110.79000091552734
    },
    "sentiment": 0.9329812526702881
  },
  {
    "title": "Gilead\u2019s Seladelpar Granted Conditional European Marketing Authorization for the Treatment of Primary Biliary Cholangitis",
    "published": 1740069183,
    "day_prices": {
      "2025-02-20T14:30:00+00:00": 107.77999877929688,
      "2025-02-20T15:30:00+00:00": 109.25,
      "2025-02-20T16:30:00+00:00": 109.25,
      "2025-02-20T17:30:00+00:00": 109.16000366210938,
      "2025-02-20T18:30:00+00:00": 109.19499969482422,
      "2025-02-20T19:30:00+00:00": 109.59500122070312,
      "2025-02-20T20:30:00+00:00": 109.62000274658203
    },
    "sentiment": 0.9192085266113281
  },
  {
    "title": "Gilead Sciences to Present at Upcoming Investor Conferences",
    "published": 1739981284,
    "day_prices": {
      "2025-02-19T14:30:00+00:00": 105.19999694824219,
      "2025-02-19T15:30:00+00:00": 106.7300033569336,
      "2025-02-19T16:30:00+00:00": 107.04000091552734,
      "2025-02-19T17:30:00+00:00": 107.15499877929688,
      "2025-02-19T18:30:00+00:00": 107.1500015258789,
      "2025-02-19T19:30:00+00:00": 106.94000244140625,
      "2025-02-19T20:30:00+00:00": 107.44000244140625
    },
    "sentiment": 0.8978155851364136
  },
  {
    "title": "BNY Mellon Global Equity Income Fund Q4 2024 Commentary",
    "published": 1739962740,
    "day_prices": {
      "2025-02-19T14:30:00+00:00": 105.19999694824219,
      "2025-02-19T15:30:00+00:00": 106.7300033569336,
      "2025-02-19T16:30:00+00:00": 107.04000091552734,
      "2025-02-19T17:30:00+00:00": 107.15499877929688,
      "2025-02-19T18:30:00+00:00": 107.1500015258789,
      "2025-02-19T19:30:00+00:00": 106.94000244140625,
      "2025-02-19T20:30:00+00:00": 107.44000244140625
    },
    "sentiment": 0.9401212334632874
  },
  {
    "title": "Nurix Therapeutics: A Story To Monitor",
    "published": 1739884338,
    "day_prices": {
      "2025-02-18T14:30:00+00:00": 104.0999984741211,
      "2025-02-18T15:30:00+00:00": 105.88999938964844,
      "2025-02-18T16:30:00+00:00": 106.0,
      "2025-02-18T17:30:00+00:00": 106.26010131835938,
      "2025-02-18T18:30:00+00:00": 106.1449966430664,
      "2025-02-18T19:30:00+00:00": 105.43499755859375,
      "2025-02-18T20:30:00+00:00": 105.41000366210938
    },
    "sentiment": 0.9118374586105347
  },
  {
    "title": "Gilead Stock Rises 8% Post Q4 Earnings: Should You Buy or Sell?",
    "published": 1739817360,
    "day_prices": {},
    "sentiment": 0.7821118831634521
  },
  {
    "title": "Gilead Sciences, Inc. (GILD) Hit a 52 Week High, Can the Run Continue?",
    "published": 1739801714,
    "day_prices": {},
    "sentiment": 0.7758563160896301
  },
  {
    "title": "Coca-Cola, Home Depot And Walmart Among 10 Companies To Announce Dividend Increases In Second Half Of February",
    "published": 1739757520,
    "day_prices": {},
    "sentiment": 0.8117721080780029
  },
  {
    "title": "Beat The S&P 500 With An ETF Portfolio That Grows Dividend Income",
    "published": 1739602800,
    "day_prices": {},
    "sentiment": 0.8437715768814087
  },
  {
    "title": "Gilead Sciences Inc. stock underperforms Friday when compared to competitors",
    "published": 1739551020,
    "day_prices": {
      "2025-02-14T14:30:00+00:00": 105.80000305175781,
      "2025-02-14T15:30:00+00:00": 106.4000015258789,
      "2025-02-14T16:30:00+00:00": 105.77999877929688,
      "2025-02-14T17:30:00+00:00": 105.03500366210938,
      "2025-02-14T18:30:00+00:00": 105.1449966430664,
      "2025-02-14T19:30:00+00:00": 104.91999816894531,
      "2025-02-14T20:30:00+00:00": 104.48999786376953
    },
    "sentiment": 0.944282591342926
  },
  {
    "title": "Biotech Stock Roundup: GILD Up on Q4 Results, BIIB, BMY Down on 2025 Guidance",
    "published": 1739469720,
    "day_prices": {
      "2025-02-13T14:30:00+00:00": 104.8499984741211,
      "2025-02-13T15:30:00+00:00": 104.8499984741211,
      "2025-02-13T16:30:00+00:00": 105.0199966430664,
      "2025-02-13T17:30:00+00:00": 104.86000061035156,
      "2025-02-13T18:30:00+00:00": 105.58000183105469,
      "2025-02-13T19:30:00+00:00": 106.15499877929688,
      "2025-02-13T20:30:00+00:00": 105.5999984741211
    },
    "sentiment": 0.5621864199638367
  },
  {
    "title": "3 US Stocks Estimated Up To 48.1% Undervalued Based On Intrinsic Value Estimates",
    "published": 1739440937,
    "day_prices": {
      "2025-02-13T14:30:00+00:00": 104.8499984741211,
      "2025-02-13T15:30:00+00:00": 104.8499984741211,
      "2025-02-13T16:30:00+00:00": 105.0199966430664,
      "2025-02-13T17:30:00+00:00": 104.86000061035156,
      "2025-02-13T18:30:00+00:00": 105.58000183105469,
      "2025-02-13T19:30:00+00:00": 106.15499877929688,
      "2025-02-13T20:30:00+00:00": 105.5999984741211
    },
    "sentiment": 0.9525454640388489
  },
  {
    "title": "Gilead Hits Buy Zone After Obliterating Fourth-Quarter Expectations",
    "published": 1739395089,
    "day_prices": {
      "2025-02-12T14:30:00+00:00": 101.73500061035156,
      "2025-02-12T15:30:00+00:00": 104.41999816894531,
      "2025-02-12T16:30:00+00:00": 103.45500183105469,
      "2025-02-12T17:30:00+00:00": 102.53500366210938,
      "2025-02-12T18:30:00+00:00": 102.61499786376953,
      "2025-02-12T19:30:00+00:00": 102.05999755859375,
      "2025-02-12T20:30:00+00:00": 102.63999938964844
    },
    "sentiment": 0.6734593510627747
  },
  {
    "title": "Why Gilead Sciences (GILD) Stock Is Trading Up Today",
    "published": 1739386174,
    "day_prices": {
      "2025-02-12T14:30:00+00:00": 101.73500061035156,
      "2025-02-12T15:30:00+00:00": 104.41999816894531,
      "2025-02-12T16:30:00+00:00": 103.45500183105469,
      "2025-02-12T17:30:00+00:00": 102.53500366210938,
      "2025-02-12T18:30:00+00:00": 102.61499786376953,
      "2025-02-12T19:30:00+00:00": 102.05999755859375,
      "2025-02-12T20:30:00+00:00": 102.63999938964844
    },
    "sentiment": 0.557399332523346
  },
  {
    "title": "Gilead Sciences (GILD) is a Top-Ranked Value Stock: Should You Buy?",
    "published": 1739371211,
    "day_prices": {
      "2025-02-12T14:30:00+00:00": 101.73500061035156,
      "2025-02-12T15:30:00+00:00": 104.41999816894531,
      "2025-02-12T16:30:00+00:00": 103.45500183105469,
      "2025-02-12T17:30:00+00:00": 102.53500366210938,
      "2025-02-12T18:30:00+00:00": 102.61499786376953,
      "2025-02-12T19:30:00+00:00": 102.05999755859375,
      "2025-02-12T20:30:00+00:00": 102.63999938964844
    },
    "sentiment": 0.9215745329856873
  },
  {
    "title": "Q4 2024 Gilead Sciences Inc Earnings Call",
    "published": 1739364645,
    "day_prices": {
      "2025-02-12T14:30:00+00:00": 101.73500061035156,
      "2025-02-12T15:30:00+00:00": 104.41999816894531,
      "2025-02-12T16:30:00+00:00": 103.45500183105469,
      "2025-02-12T17:30:00+00:00": 102.53500366210938,
      "2025-02-12T18:30:00+00:00": 102.61499786376953,
      "2025-02-12T19:30:00+00:00": 102.05999755859375,
      "2025-02-12T20:30:00+00:00": 102.63999938964844
    },
    "sentiment": 0.6881588697433472
  },
  {
    "title": "Trending tickers: Intel, Alibaba, Super Micro, Lyft and Barratt Redrow",
    "published": 1739357172,
    "day_prices": {
      "2025-02-12T14:30:00+00:00": 101.73500061035156,
      "2025-02-12T15:30:00+00:00": 104.41999816894531,
      "2025-02-12T16:30:00+00:00": 103.45500183105469,
      "2025-02-12T17:30:00+00:00": 102.53500366210938,
      "2025-02-12T18:30:00+00:00": 102.61499786376953,
      "2025-02-12T19:30:00+00:00": 102.05999755859375,
      "2025-02-12T20:30:00+00:00": 102.63999938964844
    },
    "sentiment": 0.9420602917671204
  },
  {
    "title": "Gilead Sciences: Strong Q4 Results And Huge Progress In HIV",
    "published": 1739348729,
    "day_prices": {
      "2025-02-12T14:30:00+00:00": 101.73500061035156,
      "2025-02-12T15:30:00+00:00": 104.41999816894531,
      "2025-02-12T16:30:00+00:00": 103.45500183105469,
      "2025-02-12T17:30:00+00:00": 102.53500366210938,
      "2025-02-12T18:30:00+00:00": 102.61499786376953,
      "2025-02-12T19:30:00+00:00": 102.05999755859375,
      "2025-02-12T20:30:00+00:00": 102.63999938964844
    },
    "sentiment": 0.9514998197555542
  },
  {
    "title": "Gilead Sciences (GILD) Q4 2024 Earnings Call Transcript",
    "published": 1739330123,
    "day_prices": {
      "2025-02-12T14:30:00+00:00": 101.73500061035156,
      "2025-02-12T15:30:00+00:00": 104.41999816894531,
      "2025-02-12T16:30:00+00:00": 103.45500183105469,
      "2025-02-12T17:30:00+00:00": 102.53500366210938,
      "2025-02-12T18:30:00+00:00": 102.61499786376953,
      "2025-02-12T19:30:00+00:00": 102.05999755859375,
      "2025-02-12T20:30:00+00:00": 102.63999938964844
    },
    "sentiment": 0.916851282119751
  },
  {
    "title": "Gilead Sciences (GILD) Tops Q4 Earnings and Revenue Estimates",
    "published": 1739311805,
    "day_prices": {
      "2025-02-11T14:30:00+00:00": 95.33000183105469,
      "2025-02-11T15:30:00+00:00": 95.26000213623047,
      "2025-02-11T16:30:00+00:00": 95.52999877929688,
      "2025-02-11T17:30:00+00:00": 95.67500305175781,
      "2025-02-11T18:30:00+00:00": 95.79000091552734,
      "2025-02-11T19:30:00+00:00": 95.69999694824219,
      "2025-02-11T20:30:00+00:00": 95.83999633789062
    },
    "sentiment": 0.9417701959609985
  },
  {
    "title": "Gilead Sciences, Inc. (GILD) Q4 2024 Earnings Call Transcript",
    "published": 1739306437,
    "day_prices": {
      "2025-02-11T14:30:00+00:00": 95.33000183105469,
      "2025-02-11T15:30:00+00:00": 95.26000213623047,
      "2025-02-11T16:30:00+00:00": 95.52999877929688,
      "2025-02-11T17:30:00+00:00": 95.67500305175781,
      "2025-02-11T18:30:00+00:00": 95.79000091552734,
      "2025-02-11T19:30:00+00:00": 95.69999694824219,
      "2025-02-11T20:30:00+00:00": 95.83999633789062
    },
    "sentiment": 0.9114727973937988
  },
  {
    "title": "Gilead Sciences 4Q Profit Up on HIV Product Sales, Dividend Raised",
    "published": 1739289720,
    "day_prices": {
      "2025-02-11T14:30:00+00:00": 95.33000183105469,
      "2025-02-11T15:30:00+00:00": 95.26000213623047,
      "2025-02-11T16:30:00+00:00": 95.52999877929688,
      "2025-02-11T17:30:00+00:00": 95.67500305175781,
      "2025-02-11T18:30:00+00:00": 95.79000091552734,
      "2025-02-11T19:30:00+00:00": 95.69999694824219,
      "2025-02-11T20:30:00+00:00": 95.83999633789062
    },
    "sentiment": 0.94119793176651
  },
  {
    "title": "Q4 Earnings Growth Continues To Climb Despite Mixed Tech Results",
    "published": 1739239800,
    "day_prices": {
      "2025-02-11T14:30:00+00:00": 95.33000183105469,
      "2025-02-11T15:30:00+00:00": 95.26000213623047,
      "2025-02-11T16:30:00+00:00": 95.52999877929688,
      "2025-02-11T17:30:00+00:00": 95.67500305175781,
      "2025-02-11T18:30:00+00:00": 95.79000091552734,
      "2025-02-11T19:30:00+00:00": 95.69999694824219,
      "2025-02-11T20:30:00+00:00": 95.83999633789062
    },
    "sentiment": 0.9506070613861084
  },
  {
    "title": "Wall Street Week Ahead",
    "published": 1739082525,
    "day_prices": {},
    "sentiment": 0.7665468454360962
  },
  {
    "title": "On The Hunt For Magnificent Earnings Growth? Check These 7 Stocks.",
    "published": 1738595374,
    "day_prices": {
      "2025-02-03T14:30:00+00:00": 97.05999755859375,
      "2025-02-03T15:30:00+00:00": 98.7300033569336,
      "2025-02-03T16:30:00+00:00": 99.05500030517578,
      "2025-02-03T17:30:00+00:00": 98.29000091552734,
      "2025-02-03T18:30:00+00:00": 98.56999969482422,
      "2025-02-03T19:30:00+00:00": 98.86499786376953,
      "2025-02-03T20:30:00+00:00": 98.66000366210938
    },
    "sentiment": 0.916823148727417
  },
  {
    "title": "J.P. Morgan Healthcare Conference 2025: Healthcare's Roadmap For The Year Ahead",
    "published": 1738720500,
    "day_prices": {
      "2025-02-05T14:30:00+00:00": 98.4800033569336,
      "2025-02-05T15:30:00+00:00": 99.66790008544922,
      "2025-02-05T16:30:00+00:00": 100.04499816894531,
      "2025-02-05T17:30:00+00:00": 99.75,
      "2025-02-05T18:30:00+00:00": 99.96499633789062,
      "2025-02-05T19:30:00+00:00": 100.37999725341797,
      "2025-02-05T20:30:00+00:00": 99.55999755859375
    },
    "sentiment": 0.866245687007904
  },
  {
    "title": "Eli Lilly Vs. Novo Nordisk: Which Is The Better Bargain For Investors",
    "published": 1743310800,
    "day_prices": {},
    "sentiment": 0.735475480556488
  },
  {
    "title": "abrdn Healthcare Investors Q4 2024 Commentary",
    "published": 1743303000,
    "day_prices": {},
    "sentiment": 0.9452806711196899
  },
  {
    "title": "Gilead Says CEO Daniel O'Day's 2024 Total Compensation Was $23.7 Million - SEC Filing",
    "published": 1743093460,
    "day_prices": {
      "2025-03-27T13:30:00+00:00": 110.0,
      "2025-03-27T14:30:00+00:00": 111.0199966430664,
      "2025-03-27T15:30:00+00:00": 111.19999694824219,
      "2025-03-27T16:30:00+00:00": 111.05999755859375,
      "2025-03-27T17:30:00+00:00": 111.0250015258789,
      "2025-03-27T18:30:00+00:00": 111.22000122070312,
      "2025-03-27T19:30:00+00:00": 111.30999755859375
    },
    "sentiment": 0.7383797764778137
  },
  {
    "title": "Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead.",
    "published": 1743070920,
    "day_prices": {
      "2025-03-27T13:30:00+00:00": 110.0,
      "2025-03-27T14:30:00+00:00": 111.0199966430664,
      "2025-03-27T15:30:00+00:00": 111.19999694824219,
      "2025-03-27T16:30:00+00:00": 111.05999755859375,
      "2025-03-27T17:30:00+00:00": 111.0250015258789,
      "2025-03-27T18:30:00+00:00": 111.22000122070312,
      "2025-03-27T19:30:00+00:00": 111.30999755859375
    },
    "sentiment": 0.9064256548881531
  },
  {
    "title": "Gilead\u2019s HIV Treatments Could Face Headwinds. Why the Stock Will Still Rise.",
    "published": 1743007500,
    "day_prices": {
      "2025-03-26T13:30:00+00:00": 107.98999786376953,
      "2025-03-26T14:30:00+00:00": 109.5199966430664,
      "2025-03-26T15:30:00+00:00": 109.18499755859375,
      "2025-03-26T16:30:00+00:00": 109.26000213623047,
      "2025-03-26T17:30:00+00:00": 109.58000183105469,
      "2025-03-26T18:30:00+00:00": 109.8499984741211,
      "2025-03-26T19:30:00+00:00": 109.90499877929688
    },
    "sentiment": 0.6386655569076538
  },
  {
    "title": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
    "published": 1742920620,
    "day_prices": {
      "2025-03-25T13:30:00+00:00": 106.73999786376953,
      "2025-03-25T14:30:00+00:00": 106.83000183105469,
      "2025-03-25T15:30:00+00:00": 107.69000244140625,
      "2025-03-25T16:30:00+00:00": 107.09500122070312,
      "2025-03-25T17:30:00+00:00": 107.47000122070312,
      "2025-03-25T18:30:00+00:00": 107.18499755859375,
      "2025-03-25T19:30:00+00:00": 106.98999786376953
    },
    "sentiment": 0.9420059323310852
  },
  {
    "title": "Gilead Sciences (GILD) Stock Drops Despite Market Gains: Important Facts to Note",
    "published": 1742853015,
    "day_prices": {
      "2025-03-24T13:30:00+00:00": 107.01000213623047,
      "2025-03-24T14:30:00+00:00": 106.94999694824219,
      "2025-03-24T15:30:00+00:00": 107.05000305175781,
      "2025-03-24T16:30:00+00:00": 106.80999755859375,
      "2025-03-24T17:30:00+00:00": 106.16999816894531,
      "2025-03-24T18:30:00+00:00": 106.30000305175781,
      "2025-03-24T19:30:00+00:00": 106.80999755859375
    },
    "sentiment": 0.7316550612449646
  },
  {
    "title": "Dividend Champion, Contender, And Challenger Highlights: Week Of March 23",
    "published": 1742603490,
    "day_prices": {},
    "sentiment": 0.9072015881538391
  },
  {
    "title": "Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)",
    "published": 1742547929,
    "day_prices": {
      "2025-03-21T13:30:00+00:00": 105.16000366210938,
      "2025-03-21T14:30:00+00:00": 106.2699966430664,
      "2025-03-21T15:30:00+00:00": 105.98999786376953,
      "2025-03-21T16:30:00+00:00": 106.58499908447266,
      "2025-03-21T17:30:00+00:00": 105.94999694824219,
      "2025-03-21T18:30:00+00:00": 105.69000244140625,
      "2025-03-21T19:30:00+00:00": 105.63999938964844
    },
    "sentiment": 0.8652839064598083
  },
  {
    "title": "Incyte Had a Bad Week. Investors Are Used to It.",
    "published": 1742524200,
    "day_prices": {
      "2025-03-21T13:30:00+00:00": 105.16000366210938,
      "2025-03-21T14:30:00+00:00": 106.2699966430664,
      "2025-03-21T15:30:00+00:00": 105.98999786376953,
      "2025-03-21T16:30:00+00:00": 106.58499908447266,
      "2025-03-21T17:30:00+00:00": 105.94999694824219,
      "2025-03-21T18:30:00+00:00": 105.69000244140625,
      "2025-03-21T19:30:00+00:00": 105.63999938964844
    },
    "sentiment": 0.9494196772575378
  },
  {
    "title": "GILD Stock Down on Report of Cut in HIV Prevention Spending",
    "published": 1742497200,
    "day_prices": {
      "2025-03-20T13:30:00+00:00": 106.82499694824219,
      "2025-03-20T14:30:00+00:00": 105.62999725341797,
      "2025-03-20T15:30:00+00:00": 105.30500030517578,
      "2025-03-20T16:30:00+00:00": 105.08499908447266,
      "2025-03-20T17:30:00+00:00": 105.16000366210938,
      "2025-03-20T18:30:00+00:00": 105.26499938964844,
      "2025-03-20T19:30:00+00:00": 105.45500183105469
    },
    "sentiment": 0.9674490094184875
  },
  {
    "title": "Trump Trade: Reciprocal tariffs still to start on April 2",
    "published": 1742479258,
    "day_prices": {
      "2025-03-20T13:30:00+00:00": 106.82499694824219,
      "2025-03-20T14:30:00+00:00": 105.62999725341797,
      "2025-03-20T15:30:00+00:00": 105.30500030517578,
      "2025-03-20T16:30:00+00:00": 105.08499908447266,
      "2025-03-20T17:30:00+00:00": 105.16000366210938,
      "2025-03-20T18:30:00+00:00": 105.26499938964844,
      "2025-03-20T19:30:00+00:00": 105.45500183105469
    },
    "sentiment": 0.9334844946861267
  },
  {
    "title": "Defensive Stocks For Unpredictable Trump Policy",
    "published": 1742469633,
    "day_prices": {
      "2025-03-20T13:30:00+00:00": 106.82499694824219,
      "2025-03-20T14:30:00+00:00": 105.62999725341797,
      "2025-03-20T15:30:00+00:00": 105.30500030517578,
      "2025-03-20T16:30:00+00:00": 105.08499908447266,
      "2025-03-20T17:30:00+00:00": 105.16000366210938,
      "2025-03-20T18:30:00+00:00": 105.26499938964844,
      "2025-03-20T19:30:00+00:00": 105.45500183105469
    },
    "sentiment": 0.9074294567108154
  },
  {
    "title": "Invesco Health Care Fund Q4 2024 Commentary",
    "published": 1742461500,
    "day_prices": {
      "2025-03-20T13:30:00+00:00": 106.82499694824219,
      "2025-03-20T14:30:00+00:00": 105.62999725341797,
      "2025-03-20T15:30:00+00:00": 105.30500030517578,
      "2025-03-20T16:30:00+00:00": 105.08499908447266,
      "2025-03-20T17:30:00+00:00": 105.16000366210938,
      "2025-03-20T18:30:00+00:00": 105.26499938964844,
      "2025-03-20T19:30:00+00:00": 105.45500183105469
    },
    "sentiment": 0.944513738155365
  },
  {
    "title": "Gilead stock falls on report of HIV prevention cuts",
    "published": 1742419384,
    "day_prices": {
      "2025-03-19T13:30:00+00:00": 109.69000244140625,
      "2025-03-19T14:30:00+00:00": 106.5199966430664,
      "2025-03-19T15:30:00+00:00": 106.8499984741211,
      "2025-03-19T16:30:00+00:00": 107.01499938964844,
      "2025-03-19T17:30:00+00:00": 106.80999755859375,
      "2025-03-19T18:30:00+00:00": 106.70790100097656,
      "2025-03-19T19:30:00+00:00": 107.1050033569336
    },
    "sentiment": 0.9574922919273376
  },
  {
    "title": "Gilead Dives As HHS Reportedly Mulls Cutting HIV Prevention Funding",
    "published": 1742414525,
    "day_prices": {
      "2025-03-19T13:30:00+00:00": 109.69000244140625,
      "2025-03-19T14:30:00+00:00": 106.5199966430664,
      "2025-03-19T15:30:00+00:00": 106.8499984741211,
      "2025-03-19T16:30:00+00:00": 107.01499938964844,
      "2025-03-19T17:30:00+00:00": 106.80999755859375,
      "2025-03-19T18:30:00+00:00": 106.70790100097656,
      "2025-03-19T19:30:00+00:00": 107.1050033569336
    },
    "sentiment": 0.9543059468269348
  },
  {
    "title": "Stocks to Watch Wednesday: Nvidia, Shopify, Williams-Sonoma, Tesla",
    "published": 1742399117,
    "day_prices": {
      "2025-03-19T13:30:00+00:00": 109.69000244140625,
      "2025-03-19T14:30:00+00:00": 106.5199966430664,
      "2025-03-19T15:30:00+00:00": 106.8499984741211,
      "2025-03-19T16:30:00+00:00": 107.01499938964844,
      "2025-03-19T17:30:00+00:00": 106.80999755859375,
      "2025-03-19T18:30:00+00:00": 106.70790100097656,
      "2025-03-19T19:30:00+00:00": 107.1050033569336
    },
    "sentiment": 0.9356465339660645
  },
  {
    "title": "FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review",
    "published": 1742397180,
    "day_prices": {
      "2025-03-19T13:30:00+00:00": 109.69000244140625,
      "2025-03-19T14:30:00+00:00": 106.5199966430664,
      "2025-03-19T15:30:00+00:00": 106.8499984741211,
      "2025-03-19T16:30:00+00:00": 107.01499938964844,
      "2025-03-19T17:30:00+00:00": 106.80999755859375,
      "2025-03-19T18:30:00+00:00": 106.70790100097656,
      "2025-03-19T19:30:00+00:00": 107.1050033569336
    },
    "sentiment": 0.4979996085166931
  },
  {
    "title": "Why Gilead Sciences (GILD) Is Among the Most Undervalued Biotech Stocks to Invest In",
    "published": 1742394732,
    "day_prices": {
      "2025-03-19T13:30:00+00:00": 109.69000244140625,
      "2025-03-19T14:30:00+00:00": 106.5199966430664,
      "2025-03-19T15:30:00+00:00": 106.8499984741211,
      "2025-03-19T16:30:00+00:00": 107.01499938964844,
      "2025-03-19T17:30:00+00:00": 106.80999755859375,
      "2025-03-19T18:30:00+00:00": 106.70790100097656,
      "2025-03-19T19:30:00+00:00": 107.1050033569336
    },
    "sentiment": 0.6690489649772644
  },
  {
    "title": "Gilead Stock Falls on Report Trump Administration Wants to Cut\u00a0HIV-Prevention Funding",
    "published": 1742392800,
    "day_prices": {
      "2025-03-19T13:30:00+00:00": 109.69000244140625,
      "2025-03-19T14:30:00+00:00": 106.5199966430664,
      "2025-03-19T15:30:00+00:00": 106.8499984741211,
      "2025-03-19T16:30:00+00:00": 107.01499938964844,
      "2025-03-19T17:30:00+00:00": 106.80999755859375,
      "2025-03-19T18:30:00+00:00": 106.70790100097656,
      "2025-03-19T19:30:00+00:00": 107.1050033569336
    },
    "sentiment": 0.9603322744369507
  },
  {
    "title": "These Stocks Are Moving the Most Today: Nvidia, Tesla, Autodesk, General Mills, Signet, HealthEquity, and More",
    "published": 1742369160,
    "day_prices": {
      "2025-03-19T13:30:00+00:00": 109.69000244140625,
      "2025-03-19T14:30:00+00:00": 106.5199966430664,
      "2025-03-19T15:30:00+00:00": 106.8499984741211,
      "2025-03-19T16:30:00+00:00": 107.01499938964844,
      "2025-03-19T17:30:00+00:00": 106.80999755859375,
      "2025-03-19T18:30:00+00:00": 106.70790100097656,
      "2025-03-19T19:30:00+00:00": 107.1050033569336
    },
    "sentiment": 0.8305615782737732
  },
  {
    "title": "Dividend Income: Lanny's February 2025 Summary",
    "published": 1742301600,
    "day_prices": {
      "2025-03-18T13:30:00+00:00": 112.19000244140625,
      "2025-03-18T14:30:00+00:00": 110.38999938964844,
      "2025-03-18T15:30:00+00:00": 111.1050033569336,
      "2025-03-18T16:30:00+00:00": 111.1697998046875,
      "2025-03-18T17:30:00+00:00": 111.05000305175781,
      "2025-03-18T18:30:00+00:00": 110.80000305175781,
      "2025-03-18T19:30:00+00:00": 110.68499755859375
    },
    "sentiment": 0.9465838670730591
  },
  {
    "title": "Gilead: Growth Constraints Lead To Rating Downgrade Following 50% Rally",
    "published": 1742147002,
    "day_prices": {},
    "sentiment": 0.9645511507987976
  },
  {
    "title": "Gilead Sciences - Women's History Month Celebrated With Its Team",
    "published": 1741950669,
    "day_prices": {
      "2025-03-14T13:30:00+00:00": 112.88999938964844,
      "2025-03-14T14:30:00+00:00": 112.73999786376953,
      "2025-03-14T15:30:00+00:00": 112.41000366210938,
      "2025-03-14T16:30:00+00:00": 111.38999938964844,
      "2025-03-14T17:30:00+00:00": 111.25,
      "2025-03-14T18:30:00+00:00": 111.18000030517578,
      "2025-03-14T19:30:00+00:00": 111.23999786376953
    },
    "sentiment": 0.7212262153625488
  },
  {
    "title": "Why Gilead Sciences, Inc. (GILD) is the Best Pharma Stock to Buy According to Hedge Funds",
    "published": 1741885676,
    "day_prices": {
      "2025-03-13T13:30:00+00:00": 113.88999938964844,
      "2025-03-13T14:30:00+00:00": 114.12000274658203,
      "2025-03-13T15:30:00+00:00": 113.55999755859375,
      "2025-03-13T16:30:00+00:00": 113.36000061035156,
      "2025-03-13T17:30:00+00:00": 113.0250015258789,
      "2025-03-13T18:30:00+00:00": 113.55000305175781,
      "2025-03-13T19:30:00+00:00": 113.9749984741211
    },
    "sentiment": 0.8617749810218811
  },
  {
    "title": "Gilead (GILD) Up 10.3% Since Last Earnings Report: Can It Continue?",
    "published": 1741879829,
    "day_prices": {
      "2025-03-13T13:30:00+00:00": 113.88999938964844,
      "2025-03-13T14:30:00+00:00": 114.12000274658203,
      "2025-03-13T15:30:00+00:00": 113.55999755859375,
      "2025-03-13T16:30:00+00:00": 113.36000061035156,
      "2025-03-13T17:30:00+00:00": 113.0250015258789,
      "2025-03-13T18:30:00+00:00": 113.55000305175781,
      "2025-03-13T19:30:00+00:00": 113.9749984741211
    },
    "sentiment": 0.9539879560470581
  },
  {
    "title": "Biotech Stock Roundup: TSVT Up on BMY Deal, PTGX Up on Data & More",
    "published": 1741870680,
    "day_prices": {
      "2025-03-13T13:30:00+00:00": 113.88999938964844,
      "2025-03-13T14:30:00+00:00": 114.12000274658203,
      "2025-03-13T15:30:00+00:00": 113.55999755859375,
      "2025-03-13T16:30:00+00:00": 113.36000061035156,
      "2025-03-13T17:30:00+00:00": 113.0250015258789,
      "2025-03-13T18:30:00+00:00": 113.55000305175781,
      "2025-03-13T19:30:00+00:00": 113.9749984741211
    },
    "sentiment": 0.5824571251869202
  },
  {
    "title": "Analyst Says Gilead Sciences (GILD) is a \u2018Big Liquid\u2019 Stock You Should Pay Attention To",
    "published": 1741803386,
    "day_prices": {
      "2025-03-12T13:30:00+00:00": 113.1449966430664,
      "2025-03-12T14:30:00+00:00": 113.91000366210938,
      "2025-03-12T15:30:00+00:00": 113.87999725341797,
      "2025-03-12T16:30:00+00:00": 114.5999984741211,
      "2025-03-12T17:30:00+00:00": 114.47000122070312,
      "2025-03-12T18:30:00+00:00": 113.91000366210938,
      "2025-03-12T19:30:00+00:00": 114.02999877929688
    },
    "sentiment": 0.9073927998542786
  },
  {
    "title": "Gilead Presents New HIV Treatment And Cure Research Data",
    "published": 1741798525,
    "day_prices": {
      "2025-03-12T13:30:00+00:00": 113.1449966430664,
      "2025-03-12T14:30:00+00:00": 113.91000366210938,
      "2025-03-12T15:30:00+00:00": 113.87999725341797,
      "2025-03-12T16:30:00+00:00": 114.5999984741211,
      "2025-03-12T17:30:00+00:00": 114.47000122070312,
      "2025-03-12T18:30:00+00:00": 113.91000366210938,
      "2025-03-12T19:30:00+00:00": 114.02999877929688
    },
    "sentiment": 0.8139896988868713
  },
  {
    "title": "Gilead Presents New HIV Treatment and Cure Research Data at CROI 2025, Including an Investigational Long-Acting, Twice-Yearly Therapy Option",
    "published": 1741782600,
    "day_prices": {
      "2025-03-12T13:30:00+00:00": 113.1449966430664,
      "2025-03-12T14:30:00+00:00": 113.91000366210938,
      "2025-03-12T15:30:00+00:00": 113.87999725341797,
      "2025-03-12T16:30:00+00:00": 114.5999984741211,
      "2025-03-12T17:30:00+00:00": 114.47000122070312,
      "2025-03-12T18:30:00+00:00": 113.91000366210938,
      "2025-03-12T19:30:00+00:00": 114.02999877929688
    },
    "sentiment": 0.8177328705787659
  },
  {
    "title": "First Clinical Data for Gilead's Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet",
    "published": 1741782146,
    "day_prices": {
      "2025-03-12T13:30:00+00:00": 113.1449966430664,
      "2025-03-12T14:30:00+00:00": 113.91000366210938,
      "2025-03-12T15:30:00+00:00": 113.87999725341797,
      "2025-03-12T16:30:00+00:00": 114.5999984741211,
      "2025-03-12T17:30:00+00:00": 114.47000122070312,
      "2025-03-12T18:30:00+00:00": 113.91000366210938,
      "2025-03-12T19:30:00+00:00": 114.02999877929688
    },
    "sentiment": 0.887640655040741
  },
  {
    "title": "Tracking Renaissance Technologies 13F Portfolio - Q4 2024 Update",
    "published": 1741728555,
    "day_prices": {
      "2025-03-11T13:30:00+00:00": 116.9800033569336,
      "2025-03-11T14:30:00+00:00": 115.31999969482422,
      "2025-03-11T15:30:00+00:00": 115.05000305175781,
      "2025-03-11T16:30:00+00:00": 114.52999877929688,
      "2025-03-11T17:30:00+00:00": 114.20999908447266,
      "2025-03-11T18:30:00+00:00": 115.11000061035156,
      "2025-03-11T19:30:00+00:00": 115.24500274658203
    },
    "sentiment": 0.946245014667511
  },
  {
    "title": "Gilead Sciences, Inc. (GILD) Leerink Partners Global Healthcare Conference - (Transcript)",
    "published": 1741702445,
    "day_prices": {
      "2025-03-11T13:30:00+00:00": 116.9800033569336,
      "2025-03-11T14:30:00+00:00": 115.31999969482422,
      "2025-03-11T15:30:00+00:00": 115.05000305175781,
      "2025-03-11T16:30:00+00:00": 114.52999877929688,
      "2025-03-11T17:30:00+00:00": 114.20999908447266,
      "2025-03-11T18:30:00+00:00": 115.11000061035156,
      "2025-03-11T19:30:00+00:00": 115.24500274658203
    },
    "sentiment": 0.9334596395492554
  },
  {
    "title": "Buy 5 Non-Tech High-Flying Nasdaq Stocks Amid Index's Recent Bloodbath",
    "published": 1741698720,
    "day_prices": {
      "2025-03-11T13:30:00+00:00": 116.9800033569336,
      "2025-03-11T14:30:00+00:00": 115.31999969482422,
      "2025-03-11T15:30:00+00:00": 115.05000305175781,
      "2025-03-11T16:30:00+00:00": 114.52999877929688,
      "2025-03-11T17:30:00+00:00": 114.20999908447266,
      "2025-03-11T18:30:00+00:00": 115.11000061035156,
      "2025-03-11T19:30:00+00:00": 115.24500274658203
    },
    "sentiment": 0.41948384046554565
  },
  {
    "title": "Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks",
    "published": 1741683790,
    "day_prices": {
      "2025-03-11T13:30:00+00:00": 116.9800033569336,
      "2025-03-11T14:30:00+00:00": 115.31999969482422,
      "2025-03-11T15:30:00+00:00": 115.05000305175781,
      "2025-03-11T16:30:00+00:00": 114.52999877929688,
      "2025-03-11T17:30:00+00:00": 114.20999908447266,
      "2025-03-11T18:30:00+00:00": 115.11000061035156,
      "2025-03-11T19:30:00+00:00": 115.24500274658203
    },
    "sentiment": 0.8722012042999268
  },
  {
    "title": "Zacks Investment Ideas feature highlights: Gilead Sciences and Johnson & Johnson",
    "published": 1741618920,
    "day_prices": {
      "2025-03-10T13:30:00+00:00": 117.0,
      "2025-03-10T14:30:00+00:00": 119.19000244140625,
      "2025-03-10T15:30:00+00:00": 118.81999969482422,
      "2025-03-10T16:30:00+00:00": 118.87000274658203,
      "2025-03-10T17:30:00+00:00": 119.16999816894531,
      "2025-03-10T18:30:00+00:00": 118.44999694824219,
      "2025-03-10T19:30:00+00:00": 117.59500122070312
    },
    "sentiment": 0.9414283633232117
  },
  {
    "title": "Dividend Champion, Contender, And Challenger Highlights: Week Of March 9",
    "published": 1741394217,
    "day_prices": {},
    "sentiment": 0.9101141691207886
  },
  {
    "title": "5 Big Biopharmaceutical Stocks That Are Finding Favor",
    "published": 1741181460,
    "day_prices": {
      "2025-03-05T14:30:00+00:00": 114.73999786376953,
      "2025-03-05T15:30:00+00:00": 115.33499908447266,
      "2025-03-05T16:30:00+00:00": 115.12999725341797,
      "2025-03-05T17:30:00+00:00": 115.87999725341797,
      "2025-03-05T18:30:00+00:00": 115.68440246582031,
      "2025-03-05T19:30:00+00:00": 115.9800033569336,
      "2025-03-05T20:30:00+00:00": 115.83000183105469
    },
    "sentiment": 0.7547963857650757
  },
  {
    "title": "Gilead Sciences, Inc. (GILD) TD Cowen 45th Annual Healthcare Conference (Transcript)",
    "published": 1741097044,
    "day_prices": {
      "2025-03-04T14:30:00+00:00": 117.05000305175781,
      "2025-03-04T15:30:00+00:00": 116.66999816894531,
      "2025-03-04T16:30:00+00:00": 114.80000305175781,
      "2025-03-04T17:30:00+00:00": 114.12000274658203,
      "2025-03-04T18:30:00+00:00": 114.19000244140625,
      "2025-03-04T19:30:00+00:00": 114.5199966430664,
      "2025-03-04T20:30:00+00:00": 114.83999633789062
    },
    "sentiment": 0.9302170276641846
  }
]